Nombre de documents

2

CV de Nina Radosevic-Robin


Article dans une revue2 documents

  • Gaëlle Thomas, Thierry Chardès, Nadège Gaborit, Caroline Mollevi, Wilhem Leconet, et al.. HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.. Oncotarget, Impact journals, 2014, 5 (16), pp.7138-48. <inserm-01075330>
  • Wilhem Leconet, Christel Larbouret, Thierry Chardès, Gaëlle Thomas, Madeline Neiveyans, et al.. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.: Anti-AXL mAb for pancreatic cancer immunotherapy. Oncogene, Nature Publishing Group, 2014, 33 (47), pp.5405-14. <10.1038/onc.2013.487>. <inserm-00916587>